Use of inpatient palliative care in metastatic urethral cancer

CONCLUSION: IPC use in metastatic urethral cancer increased from a marginal rate of 5.8% to as high as 28%. Ideally, differences according to sex, metastatic site, and region should be addressed to improve IPC use rates.PMID:38627106 | DOI:10.1016/j.urolonc.2024.03.019

Source: Urologic Oncology - April 16, 2024 Category: Urology & Nephrology Authors: Carolin Siech Andrea Baudo Mario de Angelis Letizia Maria Ippolita Jannello Francesco Di Bello Jordan A Goyal Zhe Tian Fred Saad Shahrokh F Shariat Nicola Longo Luca Carmignani Ottavio de Cobelli Alberto Briganti S éverine Banek Philipp Mandel Luis A Klu Source Type: research